查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1351121

2030 年肾造口设备市场预测 - 按产品类型、最终用户和地区分類的全球分析

Nephrostomy Devices Market Forecasts to 2030 - Global Analysis By Product Type, End User, and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 175+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球肾造口器材市场规模为 15.050 亿美元，预计到 2030 年将达到 28.871 亿美元，预测期内年复合成长率为 9.8%。

为了从肾臟排放尿液，需要透过皮肤插入一根称为肾造口管的细柔性管。此管用于暂时排放阻塞的尿液。在体外，塑胶袋与管子连接以收集体液。肾造口术有助于保持肾臟健康并免受损伤和感染。肾造口术还允许医生使用超音波、X 光或显影剂剂注射来观察输尿管，这有助于诊断潜在的问题。

据加拿大肾臟基金会称，肾结石在加拿大很常见，而且发病率似乎呈上升趋势，尤其是在过去 25年度中。据估计，大约 12% 的男性和 6% 的女性会在一生中的某个阶段患上肾结石。

泌尿系统疾病增加

肾臟病、肾结石、闭尿症、膀胱癌、前列腺癌等泌尿系统疾病发生率的增加以及经皮肾造口术治疗的增加是预测期内影响市场的主要要素。此外，老年人口更容易患上需要长期照护的慢性病，​​例如失禁、消化困难和慢性病。因此，世界老年人口的成长预计将成为强大的推动力。此外，随着人口高龄化，泌尿系统手术数量将增加，这将推动市场成长。

产生负面后果

人们常担心的是肾造口管放置部位的感染。医疗保健专业人员采取预防措施来降低这种风险，包括在治疗期间采用无菌程序并指导患者进行适当的护理和维护。肾造口术期间或之后可能会发生出血，这可能发生在特殊情况下，需要额外的医疗照护。有些人对敷料或肾造口管中的成分有过敏反应。当不再需要肾造口管时，移除部位可能会出现轻微出血、不适和疼痛，阻碍市场成长。

微创手术需求不断成长

对侵入性手术的需求增加以及成功率更高的肾臟造口设备的技术发展等要素将在预测期内推动市场。对于因肾臟阻塞或感染疾病而感到疼痛的患者，肾造口术可以透过减轻肾臟压力和减少发炎来显着缓解疼痛。此外，肾臟能够过滤废物并继续维持液体平衡，为市场成长创造了广泛的机会。

替代技术的可用性

肾造口术替代技术的出现对患者照护既有正面的影响，也有负面的影响。可能会在没有仔细评估患者的需求和医疗状况的情况下选择其他手术，这对患者护理有潜在风险。结果，结果可能不理想或可能出现困难，导致治疗不当。多种要素，包括医疗保健专业人员的经验和资源的可用性，可以极大地影响替代手术的品质。

COVID-19 的影响：

由于全球封锁导致肾臟病相关手术和咨询延误，第一波 COVID-19 对肾臟造口设备市场产生了重大影响。由于缺乏资源和人力，COVID-19 大流行迫使世界各地的泌尿系统部门重组其实践。然而，随着法规的放鬆，由于肾臟疾病发病率的增加和肾造口设备的使用增加，预计未来年度市场将扩大。

预计导丝细分市场在预测期内将是最大的

由于导丝段能够进入并帮助通过各种管腔结构，因此预计将显着增长。导丝是一种有效的装置。泌尿系统导丝用于在诊断和介入手术期间方便放置泌尿系统设备。肾结石疾病发生率上升，卵巢、膀胱、前列腺等恶性的频发，以及微创手术治疗需求的增加，导致肾臟问题增多，对微创肾病厂家的需求也随之增加。瘻管形成过程中对导丝的需求，预计将推动市场扩张。

门诊手术中心领域预计在预测期内年复合成长率最高

预计门诊手术中心部门在预测期内的年复合成长率最高，因为与医院和其他医疗机构相比，它提供更个体化的服务并取得更好的成果。我是。此外，ASC 不必处理治疗各种疾病和病症的问题，可以确保患者获得量身定制的护理和更好的患者体验，从而促进市场成长。

占比最大的地区：

由于有利的报销规则、不断提高的产品知名度、高素质医生的可用性以及该地区成熟的医疗机构的存在，预计北美在预测期内将占据最大的市场份额。除了技术改进的医疗用品的快速普及外，该地区肾结石患病的上升预计将增加对肾造口设备的需求。

复合年复合成长率最高的地区：

由于医院、诊所和泌尿系统专科中心等医疗保健设施的建立，预计亚太地区在预测期内将出现最高的年复合成长率。这使得需要肾臟造口手术的人更容易获得医疗保健服务，从而增加了对肾臟造口设备的需求。此外，地方政府正在製定法律并发起配合措施，以升级医疗保健系统并促进尖端医疗技术的使用。这包括泌尿系统手术的报销计划和财务援助，推动市场成长。

提供免费客製化：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和年复合成长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第1章执行摘要

第2章前言

  • 概述
  • 利害关係人
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第3章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第5章全球肾臟造口设备市场：依产品类型

  • 肾造口导管
  • 导丝
  • 扩张器鞘
  • 引流管
  • 其他产品类型

第6章全球肾臟造口设备市场：依最终用户分类

  • 门诊手术中心
  • 急诊室
  • 医院
  • 其他最终用户

第7章全球肾臟造口设备市场：依地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第8章进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第9章公司简介

  • Angiodynamics Inc
  • Argon Medical
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cardinal Health
  • Coloplast Group
  • Cook Group（Cook Medical Incorporated）
  • Envaste Limited
  • Medi-Globe GmbH
  • Meditech Devices Pvt Ltd
  • Olympus Corporation
  • Straub Medical AG
  • SURU International Pvt. Ltd
  • Teleflex Incorporated
  • Uresil LLC
Product Code: SMRC23808

According to Stratistics MRC, the Global Nephrostomy Devices Market is accounted for $1500.5 million in 2023 and is expected to reach $2887.1 million by 2030 growing at a CAGR of 9.8% during the forecast period. To drain urine from the kidney, a thin, flexible tube called a nephrostomy tube is inserted through the skin. The tube is utilized to temporarily discharge obstructed pee. A plastic bag is connected to the tube outside the body to collect the fluid. Nephrostomies can help keep the kidneys healthy and shield them from injury and infection. A nephrostomy device can also aid in the diagnosis of an underlying issue since the ureter can be seen using ultrasonography, X-rays, and contrast material injection.

According to the Kidney Foundation Canada, kidney stones are common in Canada and appear to be on the rise, especially over the last 25 years. About 12% of men and 6% of women will have a kidney stone at some point in their life.

Market Dynamics:

Driver:

Rising incidence of urological disorders

Increased incidence of urological conditions such as hydronephrosis, kidney stones, urine retention, bladder cancer, and prostate cancer and the rise in percutaneous nephrostomy treatments are the main factors impacting the market throughout the projected period. Furthermore, the geriatric population is more susceptible to chronic illnesses that need long-term care, such as incontinence, digestive difficulties, and chronic ailments. Therefore, a high-impact driver is anticipated to be an increase in the world's senior population. Additionally, the number of urological procedures performed will climb along with the aging population, which drives market growth.

Restraint:

Entailing negative outcomes

One frequent concern is infection at the location where the nephrostomy tube is placed. Healthcare professionals take preventative measures to reduce this risk, including employing sterile procedures during the treatment and giving patients the right care and maintenance instructions. During or after the nephrostomy surgery, bleeding is possible, which can happen in exceptional circumstances and call for additional medical attention. Some individuals may experience an allergic response to the components of the dressing or nephrostomy tube. There may be slight bleeding, discomfort, or pain at the removal site when the nephrostomy tube is no longer required, thus hampering the growth of the market.

Opportunity:

Rise in demand for minimal invasive operations

Over the course of the forecast period, factors like a rise in demand for less invasive operations and technical developments in nephrostomy devices with a high success rate will drive the market. For patients experiencing pain due to kidney obstruction or infections, a nephrostomy can provide significant pain relief by alleviating the pressure and reducing inflammation in the kidney. It also allows the kidney to continue filtering waste and maintaining fluid balance, creating a wide range of opportunities for market growth.

Threat:

Availability of alternative procedures

The availability of alternatives to nephrostomy surgery can affect patient care in both positive and negative ways, as different procedures may be chosen without a careful assessment of the patient's needs and medical condition, which carries both potential risks for their care. This may result in the decision to take an unsuitable course of action, which may provide less than ideal results or cause difficulties. Various factors, including the experience of the healthcare professional and the accessibility of resources, can have a significant impact on the quality of alternative operations.

COVID-19 Impact:

The initial wave of COVID-19 had a substantial influence on the market for nephrostomy devices because of the delays in nephrology-related procedures and consultations brought on by the global lockdown. The COVID-19 outbreak forced urology departments worldwide to restructure care owing to insufficient resources and manpower. However, as the regulations are loosened, the market is anticipated to expand in the years to come as a result of the rise in renal disorders and the increased use of nephrostomy devices.

The guidewires segment is expected to be the largest during the forecast period

The guidewires segment is estimated to have significant growth because of its ability to gain access and aid transit across different luminal structures. A guidewire is an effective instrument. To make the placement of endourological tools during diagnostic or interventional procedures easier, urological guidewires are used. Due to the rise in renal issues and the desire for minimally invasive kidney disease manufacturers, the rising incidence of kidney stone disorders, the frequency of ovarian, bladder, and prostate malignancies, and the rising desire for less invasive surgical treatments are anticipated to raise the need for guidewires during nephrostomy procedures, which is predicted to encourage market expansion.

The ambulatory surgical centers segment is expected to have the highest CAGR during the forecast period

The ambulatory surgical centers segment is anticipated to witness the highest CAGR during the forecast period, as they provide more individualized services and greater results in comparison to hospitals and other healthcare settings. Additionally, ASCs do not have to deal with the issue of treating a variety of diseases and disorders; they can guarantee that patients receive tailored attention with a better patient experience, thus enhancing the growth of the market.

Region with largest share:

North America is projected to hold the largest market share during the forecast period due to the advantageous reimbursement rules, rising product awareness, the availability of highly qualified physicians, and the existence of established healthcare facilities in the area. In addition to the rapid use of technologically improved medical goods, the rise in the prevalence of kidney stones in the region is expected to increase the demand for nephrostomy devices.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR over the forecast period, owing to the establishment of medical facilities such as hospitals, clinics, and urology specialty centers. This raises the need for nephrostomy devices by making healthcare services more accessible to those who need nephrostomy surgeries. Additionally, regional governments are enacting laws and launching efforts to upgrade the healthcare system and promote the use of cutting-edge medical technologies. This covers reimbursement plans and financial aid for urological procedures, thus propelling the growth of the market.

Key players in the market:

Some of the key players profiled in the Nephrostomy Devices Market include: Angiodynamics Inc, Argon Medical, B. Braun Melsungen AG., Becton, Dickinson and Company, Boston Scientific Corporation, Cardinal Health, Coloplast Group, Cook Group (Cook Medical Incorporated), Envaste Limited, Medi-Globe GmbH, Meditech Devices Pvt Ltd, Olympus Corporation, Straub Medical AG, SURU International Pvt. Ltd, Teleflex Incorporated and Uresil LLC

Key Developments:

In August 2023, Cardinal health launches next generation medical device to improve neonatal feeding, through real-time assessment technology, the NTrainer™ System provides clinicians with the objective data they need to track the progress of an infant in developing pre-feeding skills.

In June 2023, Becton, Dickinson and Company a leading global medical technology company, announced that it has signed a definitive agreement to sell its Surgical Instrumentation platform to STERIS for $540 million.

In May 2023, Argon Strengthens Biopsy Portfolio with SuperCore Advantage™ Instrument. The SuperCore Advantage is a disposable, next generation soft tissue biopsy instrument that provides a superior volume of tissue sample.

Product Types Covered:

  • Nephrostomy Catheters
  • Guidewires
  • Dilators Sheaths
  • Drainage Tubes
  • Other Product Types

End Users Covered:

  • Ambulatory Surgical Centers
  • Emergency Clinics
  • Hospitals
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Nephrostomy Devices Market, By Product Type

  • 5.1 Introduction
  • 5.2 Nephrostomy Catheters
  • 5.3 Guidewires
  • 5.4 Dilators Sheaths
  • 5.5 Drainage Tubes
  • 5.6 Other Product Types

6 Global Nephrostomy Devices Market, By End User

  • 6.1 Introduction
  • 6.2 Ambulatory Surgical Centers
  • 6.3 Emergency Clinics
  • 6.4 Hospitals
  • 6.5 Other End Users

7 Global Nephrostomy Devices Market, By Geography

  • 7.1 Introduction
  • 7.2 North America
    • 7.2.1 US
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 Italy
    • 7.3.4 France
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 Japan
    • 7.4.2 China
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 New Zealand
    • 7.4.6 South Korea
    • 7.4.7 Rest of Asia Pacific
  • 7.5 South America
    • 7.5.1 Argentina
    • 7.5.2 Brazil
    • 7.5.3 Chile
    • 7.5.4 Rest of South America
  • 7.6 Middle East & Africa
    • 7.6.1 Saudi Arabia
    • 7.6.2 UAE
    • 7.6.3 Qatar
    • 7.6.4 South Africa
    • 7.6.5 Rest of Middle East & Africa

8 Key Developments

  • 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 8.2 Acquisitions & Mergers
  • 8.3 New Product Launch
  • 8.4 Expansions
  • 8.5 Other Key Strategies

9 Company Profiling

  • 9.1 Angiodynamics Inc
  • 9.2 Argon Medical
  • 9.3 B. Braun Melsungen AG
  • 9.4 Becton, Dickinson and Company
  • 9.5 Boston Scientific Corporation
  • 9.6 Cardinal Health
  • 9.7 Coloplast Group
  • 9.8 Cook Group (Cook Medical Incorporated)
  • 9.9 Envaste Limited
  • 9.10 Medi-Globe GmbH
  • 9.11 Meditech Devices Pvt Ltd
  • 9.12 Olympus Corporation
  • 9.13 Straub Medical AG
  • 9.14 SURU International Pvt. Ltd
  • 9.15 Teleflex Incorporated
  • 9.16 Uresil LLC

List of Tables

  • Table 1 Global Nephrostomy Devices Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Nephrostomy Devices Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 3 Global Nephrostomy Devices Market Outlook, By Nephrostomy Catheters (2021-2030) ($MN)
  • Table 4 Global Nephrostomy Devices Market Outlook, By Guidewires (2021-2030) ($MN)
  • Table 5 Global Nephrostomy Devices Market Outlook, By Dilators Sheaths (2021-2030) ($MN)
  • Table 6 Global Nephrostomy Devices Market Outlook, By Drainage Tubes (2021-2030) ($MN)
  • Table 7 Global Nephrostomy Devices Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 8 Global Nephrostomy Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 9 Global Nephrostomy Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 10 Global Nephrostomy Devices Market Outlook, By Emergency Clinics (2021-2030) ($MN)
  • Table 11 Global Nephrostomy Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 12 Global Nephrostomy Devices Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 13 North America Nephrostomy Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 14 North America Nephrostomy Devices Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 15 North America Nephrostomy Devices Market Outlook, By Nephrostomy Catheters (2021-2030) ($MN)
  • Table 16 North America Nephrostomy Devices Market Outlook, By Guidewires (2021-2030) ($MN)
  • Table 17 North America Nephrostomy Devices Market Outlook, By Dilators Sheaths (2021-2030) ($MN)
  • Table 18 North America Nephrostomy Devices Market Outlook, By Drainage Tubes (2021-2030) ($MN)
  • Table 19 North America Nephrostomy Devices Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 20 North America Nephrostomy Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 21 North America Nephrostomy Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 22 North America Nephrostomy Devices Market Outlook, By Emergency Clinics (2021-2030) ($MN)
  • Table 23 North America Nephrostomy Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 24 North America Nephrostomy Devices Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 25 Europe Nephrostomy Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 26 Europe Nephrostomy Devices Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 27 Europe Nephrostomy Devices Market Outlook, By Nephrostomy Catheters (2021-2030) ($MN)
  • Table 28 Europe Nephrostomy Devices Market Outlook, By Guidewires (2021-2030) ($MN)
  • Table 29 Europe Nephrostomy Devices Market Outlook, By Dilators Sheaths (2021-2030) ($MN)
  • Table 30 Europe Nephrostomy Devices Market Outlook, By Drainage Tubes (2021-2030) ($MN)
  • Table 31 Europe Nephrostomy Devices Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 32 Europe Nephrostomy Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 33 Europe Nephrostomy Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 34 Europe Nephrostomy Devices Market Outlook, By Emergency Clinics (2021-2030) ($MN)
  • Table 35 Europe Nephrostomy Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 36 Europe Nephrostomy Devices Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 37 Asia Pacific Nephrostomy Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 38 Asia Pacific Nephrostomy Devices Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 39 Asia Pacific Nephrostomy Devices Market Outlook, By Nephrostomy Catheters (2021-2030) ($MN)
  • Table 40 Asia Pacific Nephrostomy Devices Market Outlook, By Guidewires (2021-2030) ($MN)
  • Table 41 Asia Pacific Nephrostomy Devices Market Outlook, By Dilators Sheaths (2021-2030) ($MN)
  • Table 42 Asia Pacific Nephrostomy Devices Market Outlook, By Drainage Tubes (2021-2030) ($MN)
  • Table 43 Asia Pacific Nephrostomy Devices Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 44 Asia Pacific Nephrostomy Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 45 Asia Pacific Nephrostomy Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 46 Asia Pacific Nephrostomy Devices Market Outlook, By Emergency Clinics (2021-2030) ($MN)
  • Table 47 Asia Pacific Nephrostomy Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 48 Asia Pacific Nephrostomy Devices Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 49 South America Nephrostomy Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 50 South America Nephrostomy Devices Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 51 South America Nephrostomy Devices Market Outlook, By Nephrostomy Catheters (2021-2030) ($MN)
  • Table 52 South America Nephrostomy Devices Market Outlook, By Guidewires (2021-2030) ($MN)
  • Table 53 South America Nephrostomy Devices Market Outlook, By Dilators Sheaths (2021-2030) ($MN)
  • Table 54 South America Nephrostomy Devices Market Outlook, By Drainage Tubes (2021-2030) ($MN)
  • Table 55 South America Nephrostomy Devices Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 56 South America Nephrostomy Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 57 South America Nephrostomy Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 58 South America Nephrostomy Devices Market Outlook, By Emergency Clinics (2021-2030) ($MN)
  • Table 59 South America Nephrostomy Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 60 South America Nephrostomy Devices Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 61 Middle East & Africa Nephrostomy Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 62 Middle East & Africa Nephrostomy Devices Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 63 Middle East & Africa Nephrostomy Devices Market Outlook, By Nephrostomy Catheters (2021-2030) ($MN)
  • Table 64 Middle East & Africa Nephrostomy Devices Market Outlook, By Guidewires (2021-2030) ($MN)
  • Table 65 Middle East & Africa Nephrostomy Devices Market Outlook, By Dilators Sheaths (2021-2030) ($MN)
  • Table 66 Middle East & Africa Nephrostomy Devices Market Outlook, By Drainage Tubes (2021-2030) ($MN)
  • Table 67 Middle East & Africa Nephrostomy Devices Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 68 Middle East & Africa Nephrostomy Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 69 Middle East & Africa Nephrostomy Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 70 Middle East & Africa Nephrostomy Devices Market Outlook, By Emergency Clinics (2021-2030) ($MN)
  • Table 71 Middle East & Africa Nephrostomy Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 72 Middle East & Africa Nephrostomy Devices Market Outlook, By Other End Users (2021-2030) ($MN)